×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

  • 24 January, 2021

  • 18 Min Read

COVID-19 vaccines and possible side effects

COVID-19 vaccines and possible side effects

  • Two COVID-19 vaccines, Covaxin and Covishield, after being granted emergency use authorisation, were rolled out on January 16 across India to inoculate three crore healthcare and frontline workers in the first phase of the vaccination drive.
  • Both the vaccines have been manufactured in India.
  • While Covaxin is produced under a collaboration between Bharat Biotech and the Indian Council of Medical Research, Covishield has been developed by AstraZeneca and Oxford University with the Serum Institute of India conducting clinical trials of the vaccine in the country and also manufacturing the vaccine for India and low- and middle-income countries.

What are the known side effects of the two vaccines?

  • Covishield is made of a weakened and modified version of adenovirus (a common cold virus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.
  • Common side effects of the vaccine include tenderness, pain, redness, itching, swelling or bruising, fatigue, chills or feeling feverish, headache, nausea, joint pain or muscle ache, a lump at the injection site, fever, vomiting and flu-like symptoms, such as high temperature, sore throat, runny nose, cough and chills.
  • Feeling dizzy, decreased appetite, abdominal pain, enlarged lymph nodes, excessive sweating, itchy skin or rash are the uncommon side effects of the vaccines. Apart from this, “serious and unexpected side effects may occur”, the SII has stated.
  • Bharat Biotech in its fact sheet notes that besides the listed side effects, Covaxin, in rare cases, can also cause a severe allergic reaction. “Although rare, signs of this include difficulty in breathing, swelling of your face and throat, a fast heart rate, rash all over the body and dizziness and weakness,” the company said.

Who should not be taking the vaccines?

  • Cross-use of either of the vaccines is not permitted and the vaccines are contraindicated for pregnant and lactating women.
  • Besides this, Covaxin should not be given to those who are immunocompromised or are on medication for the same, individuals with a history of allergies, those who have a fever, a bleeding disorder or are on a blood thinner, as per information released by the company.
  • Similarly, Covishield, which is allowed for restricted use in emergency situations in individuals 18 years of age and older, should not be used by people who have had a severe allergic reaction to any ingredient of the vaccine or had a severe allergic reaction after a previous dose.
  • Beneficiaries are also to tell medical staff about any bleeding disorder, an immunocompromised medical condition, and the medication for that. Healthcare workers should also be informed if the beneficiary has got another vaccine shot.

What should be done in case of side effects?

  • While the Health Ministry has claimed that so far, there have been no serious or severe reactions after vaccination, it is advised that you call a healthcare provider if you have any side effects that bother you or which do not go away.
  • The Ministry says that if one experiences a severe allergic reaction, they must go to the nearest hospital. The Health Ministry has now also updated its Co-WIN system for “enhanced safety of the beneficiaries”.
  • It said the enhanced system allows tagging of contraindications in the vaccinator module.
  • “The improved module also allows the creation of more session sites and change in site location. It also facilitates the planning and scheduling of the sessions for the entire week,” added the Ministry.

Source: TH


India–Azerbaijan

A year after tensions arising from Operation Sindoor, India and Azerbaijan have taken steps to restore and normalise bilateral relations. The 6th round of Foreign Office Consultations, held in Baku, marked the first such engagement since 2022, signaling renewed diplomatic momentum. Recent Diplomatic Engagement During the consultations, bo

India–Australia Economic Cooperation and Trade Agreem

The India–Australia Economic Cooperation and Trade Agreement has completed four years since its signing. Both countries now aim to build on this progress through strengthened collaboration and ambitious targets, including reaching AUD 100 billion in bilateral trade by 2030. What is the India–Australia Economic Cooperation and Tra

ADR Report on Political Funding

A recent report by the Association for Democratic Reforms (ADR) analyses donations of ?20,000 or more declared to the Election Commission of India (ECI) by national political parties for FY 2024–25, highlighting transparency and accountability in political financing. Key Findings Massive Funding Surge Total donations to nationa

Maritime Chokepoints

Maritime chokepoints are narrow channels along global shipping routes where maritime traffic is concentrated. These points are geopolitically and economically critical, as they handle a large proportion of global trade, especially energy shipments. Current Relevance Over two-thirds of seaborne energy trade passes through a handful o

US-Israel-Iran War

Following the launch of Operation Epic Fury (U.S.) and Operation Roaring Lion (Israel), the geopolitical landscape has shifted fundamentally with the confirmed death of Iran’s Supreme Leader, Ayatollah Ali Khamenei.Iran retaliated through Operation True Promise 4, launching missile attacks against Israel and nearby Gulf states. The escala

DNA

05 Apr,2026

Toppers

Search By Date

Newsletter Subscription
SMS Alerts

Important Links

UPSC GS Mains Crash Course - RAW